Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Greggio

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Brain : a Journal of Neurology|April 20, 2021
LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregationFrancesca Pischedda, Maria Daniela Cirnaru, Luisa Ponzoni, et al.
Human Molecular Genetics|April 29, 2017
GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2Marian Blanca Ramírez, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.
The Journal of Biological Chemistry|April 10, 2008
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylationElisa Greggio, Ibardo Zambrano, Alice Kaganovich, et al.
Journal of Neurochemistry|June 1, 2019
Leucine-rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre-synaptic sitesAntonella Marte, Isabella Russo, Claudia Rebosio, et al.
Human Molecular Genetics|June 5, 2014
The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicityNicoletta Plotegher, Dhruv Kumar, Isabella Tessari, et al.
Plos One|September 7, 2012
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimersLaura Civiero, Renée Vancraenenbroeck, Elisa Belluzzi, et al.
Acta Neuropathologica Communications|March 16, 2017
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 miceFrancesco Longo, Daniela Mercatelli, Salvatore Novello, et al.
Molecular Neurobiology|February 25, 2021
Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein ClearanceLinn Streubel-Gallasch, Veronica Giusti, Michele Sandre, et al.
Molecular Neurodegeneration|January 14, 2016
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rateElisa Belluzzi, Adriano Gonnelli, Maria-Daniela Cirnaru, et al.
Journal of Neurochemistry|March 19, 2005
Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's diseaseElisa Greggio, Elisabetta Bergantino, Donald Carter, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Brain : a Journal of Neurology|April 20, 2021
LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregationFrancesca Pischedda, Maria Daniela Cirnaru, Luisa Ponzoni, et al.
Human Molecular Genetics|April 29, 2017
GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2Marian Blanca Ramírez, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.
The Journal of Biological Chemistry|April 10, 2008
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylationElisa Greggio, Ibardo Zambrano, Alice Kaganovich, et al.
Journal of Neurochemistry|June 1, 2019
Leucine-rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre-synaptic sitesAntonella Marte, Isabella Russo, Claudia Rebosio, et al.
Human Molecular Genetics|June 5, 2014
The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicityNicoletta Plotegher, Dhruv Kumar, Isabella Tessari, et al.
Plos One|September 7, 2012
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimersLaura Civiero, Renée Vancraenenbroeck, Elisa Belluzzi, et al.
Acta Neuropathologica Communications|March 16, 2017
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 miceFrancesco Longo, Daniela Mercatelli, Salvatore Novello, et al.
Molecular Neurobiology|February 25, 2021
Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein ClearanceLinn Streubel-Gallasch, Veronica Giusti, Michele Sandre, et al.
Molecular Neurodegeneration|January 14, 2016
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rateElisa Belluzzi, Adriano Gonnelli, Maria-Daniela Cirnaru, et al.
Journal of Neurochemistry|March 19, 2005
Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's diseaseElisa Greggio, Elisabetta Bergantino, Donald Carter, et al.
Pageof 10